Child-Parent Familial Hypercholesterolemia Screening
Recruiting now
Conditions studied: Familial Hypercholesterolemia
In brief
Child-parent screening for familial hypercholesterolemia has been proposed to identify children and their parent who are carrier of mutations and with high risk for inherited premature coronary artery disease. The investigators assessed the efficacy and feasibility of such screening in primary care practice. key scientific questions: 1. The 95th and 99th percentile of finger blood TC in children of 2 years old. 2. Mutations that contribute to high TC status ( serum TC \>99th percentiles) compared with international FH48 panel for FH genetic screening.
Key facts
- Study ID
- NCT04529967
- Run by
- Children's Hospital of Fudan University
- People needed
- 15000
- Starts
- 2025-04-01
- Expected to finish
- 2026-09-30
- Last updated by the study team
- 2026-05-15
Who can join
Age: 1 and older, up to 3. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Receive routine child care
- aged 1 - 3 years old ( date of investigate minus date of birth)
You may not qualify if…
- It is up to the researcher to decide whether it is suitable to participate in this research
Where it is running
- Anhui Provincial Children's Hospital — Hefei, Anhui, China (enrolling)
- Qidong Women and Children Hospital — Qidong, Jiangsu, China (enrolling)
- Weili Yan — Shanghai, Shanghai Municipality, China (enrolling)
- Shanxi Provincial Children's Hospital — Taiyuan, Shanxi, China (enrolling)
- Chongqin Medical University Affiliated Children's Hospital — Chongqing, Sichuan, China (enrolling)
- Urumqi Children's Hospital — Ürümqi, Xinjiang, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.